ASP Isotopes Inc

NASDAQ:ASPI

ASP Isotopes, Inc. is a pre-commercial stage advanced materials company, which engages in the development of technology and processes that will allow for the enrichment of natural isotopes into higher concentration products. The company is headquartered in Boca Raton, Florida and currently employs 4 full-time employees. The company went IPO on 2022-11-10. The firm has developed the aerodynamic separation process (ASP technology) for the production, distribution, marketing, and sale of all isotopes. Its technology allows it to enrich elements with both low and high atomic masses. The Company’s focus is on the production and commercialization of enriched Molybdenum-100 (Mo-100). The company also intends to use the ASP technology licensed to produce enriched Uranium-235 (U-235). The company operates principally through subsidiaries: ASP Isotopes Guernsey Limited, which is focused on the development and commercialization of high value, low volume isotopes for specialized end markets (such as Mo-100 and others, including Silicon-28); Enriched Energy LLC, which is focused on the development and commercialization of uranium for the nuclear energy market; and ASP Isotopes UK Ltd, which is the licensee of the ASP technology under the exclusive license agreement with Klydon Proprietary Ltd.